Plus Therapeutics Inc (PSTV) volume exceeds 0.57 million: A new investment opportunity for investors

On November 20, 2023, Plus Therapeutics Inc (NASDAQ: PSTV) opened at $2.22, lower -27.76% from the last session. During the day, the shares moved up to $2.50 and dropped to $1.66 before settling in for the closing price of $2.63. Price fluctuations for PSTV have ranged from $0.97 to $7.35 over the past 52 weeks.

Elon Musk just Triggered a BOOM in These Stocks

Something strange is happening in the stock market…. This select group of stocks are going absolutely bananas. And it's all because of Elon Musk. Get your copy of "Top 5 Tech Stocks to Buy in 2024"

Click Here to Download the FREE Report.


Annual sales at Healthcare sector company slipped by -10.03% over the past five years. Company’s average yearly earnings per share was noted 58.10% at the time writing. With a float of $4.42 million, this company’s outstanding shares have now reached $4.52 million.

Let’s look at the performance matrix of the company that is accounted for 17 employees. In terms of profitability, gross margin is -217.86, operating margin of -8800.00, and the pretax margin is -9051.34.

Plus Therapeutics Inc (PSTV) Insider Updates

A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Plus Therapeutics Inc is 2.23%, while institutional ownership is 1.95%. The most recent insider transaction that took place on Nov 16, was worth 1,950. In this transaction Director of this company bought 1,000 shares at a rate of $1.95, taking the stock ownership to the 25,160 shares. Before that another transaction happened on Nov 15, when Company’s Director bought 1,000 for $1.77, making the entire transaction worth $1,770. This insider now owns 24,160 shares in total.

Plus Therapeutics Inc (PSTV) Performance Highlights and Predictions

If we go through the results of last quarter, which was made public on 9/29/2023, the company posted -$1 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -$1.12) by $0.12. This company achieved a net margin of -9051.34 while generating a return on equity of -234.65. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.4 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 58.10% per share during the next fiscal year.

Plus Therapeutics Inc (NASDAQ: PSTV) Trading Performance Indicators

Check out the current performance indicators for Plus Therapeutics Inc (PSTV). In the past quarter, the stock posted a quick ratio of 1.10. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.29.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -6.19, a number that is poised to hit -1.17 in the next quarter and is forecasted to reach -2.37 in one year’s time.

Technical Analysis of Plus Therapeutics Inc (PSTV)

Plus Therapeutics Inc (NASDAQ: PSTV) saw its 5-day average volume 0.35 million, a positive change from its year-to-date volume of 0.22 million. As of the previous 9 days, the stock’s Stochastic %D was 73.71%. Additionally, its Average True Range was 0.27.

During the past 100 days, Plus Therapeutics Inc’s (PSTV) raw stochastic average was set at 41.53%, which indicates a significant decrease from 43.59% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 203.26% in the past 14 days, which was higher than the 169.16% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $1.36, while its 200-day Moving Average is $3.05. Nevertheless, the first resistance level for the watch stands at $2.38 in the near term. At $2.86, the stock is likely to face the second major resistance level. The third major resistance level sits at $3.22. If the price goes on to break the first support level at $1.54, it is likely to go to the next support level at $1.18. Assuming the price breaks the second support level, the third support level stands at $0.70.

Plus Therapeutics Inc (NASDAQ: PSTV) Key Stats

There are currently 4,523K shares outstanding in the company with a market cap of 8.59 million. Presently, the company’s annual sales total 220 K according to its annual income of -20,280 K. Last quarter, the company’s sales amounted to 1,240 K and its income totaled -3,220 K.


On What Basis Did Swvl Holdings Corp (SWVL) Stock Rise 47% Pre-Hours?

When last checked, Swvl Holdings Corp. (Nasdaq: SWVL), a...

What Drove Organovo (ONVO) Stock Up 15% In After-Hour Session On Tuesday?

Shares of Organovo Holdings Inc. (Nasdaq: ONVO) were up...

Is There Any Reason As To Why The Zai Lab (ZLAB) Stock Expanded By 13%?

The biopharmaceutical business Zai Lab Limited (NASDAQ: ZLAB), which...



Don't miss

Wearable Devices (WLDS) Stock Rose 12% On Tuesday, But On What Basis?

Wearable Devices Ltd (NASD: WLDS) is experiencing significant growth...

Did Anything Boost ObsEva (OBSV) Stock In Pre-Hours Trading?

Following an update, shares of ObsEva SA (NASD: OBSV)...

How Did The Kalera (KAL) Stock Rise 32% Pre-Hours?

At the time of the most recent check, shares...

Why Has Selina Hospitality (SLNA) Stock Increased In Extended Session On Friday?

The stock of Selina Hospitality PLC (NASD: SLNA), which...

Rocket Pharmaceuticals Inc (RCKT) surge 12.73% in a week: will this be a lucky break through?

Rocket Pharmaceuticals Inc (NASDAQ: RCKT) started the day on December 07, 2023, with a price increase of 1.82% at $26.30. During the day, the...

California Resources Corporation (CRC) Open at price of $49.34: A Brand-New Opportunity for Investors

California Resources Corporation (NYSE: CRC) open the trading on December 07, 2023, with a bit cautious approach as it glided -0.14% to $49.12. During...

Wayfair Inc (W) Open at price of $52.35: A Brand-New Opportunity for Investors

Witnessing the stock’s movement on the chart, on December 07, 2023, Wayfair Inc (NYSE: W) remained unchanged to $53.07. During the day, the stock...


Please enter your comment!
Please enter your name here